The role of proprotein convertase subtilisin-kexin type 9 (PCSK9) in the vascular aging process – is there a link?

Lately there are many new, promising low-density lipoprotein cholesterol reducing therapies with PCSK9 inhibitors. We performed selected sampling of the publications in PubMed and made a review according to selected keywords. It summarizes the effect of PCSK9 on vascular aging, directly associated w...

Full description

Bibliographic Details
Main Authors: Malwina Grobelna, Ewa Strauss, Zbigniew Krasiński
Format: Article
Language:English
Published: Termedia Publishing House 2019-10-01
Series:Polish Journal of Thoracic and Cardiovascular Surgery
Subjects:
Online Access:https://www.termedia.pl/The-role-of-proprotein-convertase-subtilisin-kexin-type-9-PCSK9-in-the-vascular-aging-process-is-there-a-link-,40,37944,1,1.html
_version_ 1818305361229119488
author Malwina Grobelna
Ewa Strauss
Zbigniew Krasiński
author_facet Malwina Grobelna
Ewa Strauss
Zbigniew Krasiński
author_sort Malwina Grobelna
collection DOAJ
description Lately there are many new, promising low-density lipoprotein cholesterol reducing therapies with PCSK9 inhibitors. We performed selected sampling of the publications in PubMed and made a review according to selected keywords. It summarizes the effect of PCSK9 on vascular aging, directly associated with lipid and glucose metabolism, chronic inflammation, atherosclerosis and hypertension. Serum level of PCSK9 is different in patients affected by certain illnesses (whose risk increases with age) than in healthy individuals. The same could be observed in the case of chronic inflammation. In this review we summarize what is known about the role PCSK9 in human metabolism and how this could affect the vascular aging process. Based on the available sources, we prove that PCSK9 is involved in many biochemical pathways associated with vascular aging. In the future, treatments using PCSK9 inhibition may not only reduce the cardiovascular risk but also slow down this process.
first_indexed 2024-12-13T06:25:22Z
format Article
id doaj.art-0598e6ab8ff04192a398ee07eb855b30
institution Directory Open Access Journal
issn 1731-5530
1897-4252
language English
last_indexed 2024-12-13T06:25:22Z
publishDate 2019-10-01
publisher Termedia Publishing House
record_format Article
series Polish Journal of Thoracic and Cardiovascular Surgery
spelling doaj.art-0598e6ab8ff04192a398ee07eb855b302022-12-21T23:56:44ZengTermedia Publishing HousePolish Journal of Thoracic and Cardiovascular Surgery1731-55301897-42522019-10-0116312813210.5114/kitp.2019.8860237944The role of proprotein convertase subtilisin-kexin type 9 (PCSK9) in the vascular aging process – is there a link?Malwina GrobelnaEwa StraussZbigniew KrasińskiLately there are many new, promising low-density lipoprotein cholesterol reducing therapies with PCSK9 inhibitors. We performed selected sampling of the publications in PubMed and made a review according to selected keywords. It summarizes the effect of PCSK9 on vascular aging, directly associated with lipid and glucose metabolism, chronic inflammation, atherosclerosis and hypertension. Serum level of PCSK9 is different in patients affected by certain illnesses (whose risk increases with age) than in healthy individuals. The same could be observed in the case of chronic inflammation. In this review we summarize what is known about the role PCSK9 in human metabolism and how this could affect the vascular aging process. Based on the available sources, we prove that PCSK9 is involved in many biochemical pathways associated with vascular aging. In the future, treatments using PCSK9 inhibition may not only reduce the cardiovascular risk but also slow down this process.https://www.termedia.pl/The-role-of-proprotein-convertase-subtilisin-kexin-type-9-PCSK9-in-the-vascular-aging-process-is-there-a-link-,40,37944,1,1.htmlvascular aging pcsk9 atherosclerosis inflammation cholesterol
spellingShingle Malwina Grobelna
Ewa Strauss
Zbigniew Krasiński
The role of proprotein convertase subtilisin-kexin type 9 (PCSK9) in the vascular aging process – is there a link?
Polish Journal of Thoracic and Cardiovascular Surgery
vascular aging
pcsk9
atherosclerosis
inflammation
cholesterol
title The role of proprotein convertase subtilisin-kexin type 9 (PCSK9) in the vascular aging process – is there a link?
title_full The role of proprotein convertase subtilisin-kexin type 9 (PCSK9) in the vascular aging process – is there a link?
title_fullStr The role of proprotein convertase subtilisin-kexin type 9 (PCSK9) in the vascular aging process – is there a link?
title_full_unstemmed The role of proprotein convertase subtilisin-kexin type 9 (PCSK9) in the vascular aging process – is there a link?
title_short The role of proprotein convertase subtilisin-kexin type 9 (PCSK9) in the vascular aging process – is there a link?
title_sort role of proprotein convertase subtilisin kexin type 9 pcsk9 in the vascular aging process is there a link
topic vascular aging
pcsk9
atherosclerosis
inflammation
cholesterol
url https://www.termedia.pl/The-role-of-proprotein-convertase-subtilisin-kexin-type-9-PCSK9-in-the-vascular-aging-process-is-there-a-link-,40,37944,1,1.html
work_keys_str_mv AT malwinagrobelna theroleofproproteinconvertasesubtilisinkexintype9pcsk9inthevascularagingprocessistherealink
AT ewastrauss theroleofproproteinconvertasesubtilisinkexintype9pcsk9inthevascularagingprocessistherealink
AT zbigniewkrasinski theroleofproproteinconvertasesubtilisinkexintype9pcsk9inthevascularagingprocessistherealink
AT malwinagrobelna roleofproproteinconvertasesubtilisinkexintype9pcsk9inthevascularagingprocessistherealink
AT ewastrauss roleofproproteinconvertasesubtilisinkexintype9pcsk9inthevascularagingprocessistherealink
AT zbigniewkrasinski roleofproproteinconvertasesubtilisinkexintype9pcsk9inthevascularagingprocessistherealink